Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

327
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancements in extracellular vesicle research.

Extracellular vesicle·2026
Same author

Beyond BMI: central obesity identifies overlooked fatty liver disease risk in adults with normal body mass index undergoing routine health examinations.

Frontiers in public health·2026
Same author

Aligning climate and air quality goals demands early VOC control for China's ozone pollution.

Nature communications·2026
Same author

Integrative functional genomics maps synaptic and developmental-regulatory autism risk-gene sets across human cortex.

Functional & integrative genomics·2026
Same author

Current status and progress of validation studies on the ICOPE scale: a scoping review.

Frontiers in public health·2026
Same author

Effects of β‑hydroxybutyrate on restoring autophagic flux and mitochondrial function in macrophages exposed to oxidized low‑density lipoprotein.

Molecular medicine reports·2026

Related Experiment Video

Updated: Jul 25, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

780

Towards artificial intelligence-enabled extracellular vesicle precision drug delivery.

Zachary F Greenberg1, Kiley S Graim2, Mei He1

  • 1Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.

Advanced Drug Delivery Reviews
|June 25, 2023
PubMed
Summary

Artificial intelligence (AI) enhances extracellular vesicle (EV) therapies for precision drug delivery. Integrating large-scale EV data with AI addresses heterogeneity challenges, paving the way for AI-directed EV therapies and clinical translation.

Keywords:
Artificial IntelligenceDrug DeliveryExtracellular Vesicles

More Related Videos

Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

440
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

2.3K

Related Experiment Videos

Last Updated: Jul 25, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

780
Characterizing Extracellular Vesicles from Biological Fluids
05:07

Characterizing Extracellular Vesicles from Biological Fluids

Published on: February 28, 2025

440
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
07:41

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

2.3K

Area of Science:

  • Nanomedicine
  • Biotechnology
  • Artificial Intelligence

Background:

  • Extracellular Vesicles (EVs), including exosomes, are promising nanomedicine drug delivery vehicles due to biocompatibility and stability.
  • EV heterogeneity poses a significant challenge for achieving precise molecular targeting in drug delivery.
  • Identifying molecular drivers for EV tissue targeting specificity is crucial for advancing EV-based therapies.

Purpose of the Study:

  • To review the integration of Artificial Intelligence (AI) with large-scale Extracellular Vesicle (EV) data for developing advanced drug delivery systems.
  • To explore the potential of AI-directed EV therapies for precision drug delivery and clinical translation.
  • To discuss the current limitations, standardization challenges, and future considerations for AI-enhanced EV therapies.

Main Methods:

  • Review of current literature on EVs in drug delivery, focusing on nanomedicine applications.
  • Integration of large-scale EV datasets with AI algorithms for predictive modeling.
  • Analysis of AI's role in engineering EVs for enhanced tissue targeting and precision control.

Main Results:

  • AI offers powerful predictive capabilities for guiding the rational design of engineered EVs.
  • AI integration with EV data can overcome heterogeneity challenges, enabling precise molecular targeting.
  • AI-directed EV therapies demonstrate significant potential for improving drug delivery efficacy and specificity.

Conclusions:

  • AI is pivotal in advancing EV-based drug delivery towards precision medicine.
  • Addressing standardization and critical considerations is essential for the successful clinical translation of AI-combined EV therapies.
  • A collaborative effort between AI and EV research is key to unlocking the full clinical potential of these novel therapies.